$BELFA

Vellucci Vincent sold $235K of BELFA

Vellucci Vincent sold 1,000 shares of BEL FUSE INC /NJ (BELFA) at $235.15 ($0.24M total) on 2026-09-14.

Original reporting
SEC EDGAR · Vellucci Vincent
Published Sep 15, 2026, 6:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 6:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BELFA
Bearish
medium confidence
Mentioned
$BELFA
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BELFABearishLow
01

Why it matters

The disclosed sale provides fresh data for short‑term traders assessing BELFA's price action.

02

Market read

A modest insider sale may prompt short‑term traders to watch BELFA for slight price weakness.

03

What to watch

No accompanying news suggests the sale is not linked to any material corporate event.

Relevance 4/10Novelty 4/10Timing: post‑market 2026‑09‑14

Background

Form 4 filings disclose insider transactions; a director's sale is publicly reported via SEC EDGAR.

Company-level read

Ticker impact

$BELFABearishMedium confidence
Context

Director Vincent Vellucci sold 1,000 shares for $235,150, reducing his stake to 7,434 shares.

Expected impact

Potential short-term dip of 1-2% as market digests the sale.

Evidence & confidence

Insider sales by a director, even modest, are often viewed as a negative signal by traders.

Market effects

Minimal impact on the broader sector; only reflects company‑specific insider activity.

No significant regional effect.

Limited to investors tracking BELFA.

Counterpoint

The sale could be routine liquidity need, not a bearish sign.

Key entities

  • BEL FUSE INC

    Issuer of the stock BELFA.

  • Vincent Vellucci

    Director of BEL FUSE INC who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BELFAHighAI 8/10

Why Bel Fuse (BELFA) Shares Are Falling Today

Bel Fuse (BELFA) shares fell 7.5% after completing a $441.6M equity offering, raising concerns about share dilution. Insider sales and technical trends added to the decline. The company plans to use proceeds to pay debt, fund an acquisition, and for general purposes. BELFA is up 26.6% YTD but down 33.5% from its 52-week high.

$ALNTHighAI 8/10

Q2 Electronic Components Earnings: Allient (NASDAQ:ALNT) Impresses

Allient (ALNT) reported Q2 revenue of $153.8M, up 10.2% YoY, beating estimates by 5.5%. The company's stock is flat since reporting. Advanced Energy (AEIS) saw 30% YoY revenue growth, outperforming expectations by 5.6%, but its stock fell 6.1%. nLIGHT (LASR) reported 33.8% YoY revenue growth, beating estimates by 4.6%, but its stock dropped 44%. Belden (BDC) reported 11.6% YoY revenue growth, in line with expectations, and its stock rose 12.5%. Bel Fuse (BELF.A) saw 25.2% YoY revenue growth, bea

$BELFAMedAI 8/10

Bel Fuse’s (NASDAQ:BELFA) Q2 CY2026 Sales Top Estimates, Guides for Strong Sales Next Quarter

Bel Fuse (NASDAQ: BELFA) reported Q2 CY2026 revenue of $210.7 million, up 25.2% year over year, topping Wall Street estimates. Management guided next-quarter revenue to $215 million at the midpoint, above analyst expectations. Non-GAAP EPS was $2.76, up from $1.58 a year earlier, and ahead of consensus. The company said it raised net proceeds of $441.6 million to pay down debt and fund Enercon-related plans.

$CRCLMed

Here Are Monday’s Best Wall Street Analyst Research Calls: Atmos Energy, Best Buy, Biogen, Capital One, Costco, Disney, Papa John’s International, Shopify, and More

The article lists Monday analyst calls and market moves. It highlights SK hynix’s Nasdaq debut, up about 12.8% to $168.01 after raising nearly $26.5B. It cites upgrades including BIIB to Buy at $235, COF to Buy at $229, and SHOP to Buy at $160, plus downgrades like BBY to Hold. Circle (CRCL) rose ~15% on OCC approval.